References
  1. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063. [PMID: 18565894]
  2. Yao JC, Eisner MP, Leary C, et al. Population based study of islet cell carcinoma. Ann Surg Oncol 2007;14:3492. [PMID: 17896148]
  3. Lam KY, Lo CY. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 1997;23:36. [PMID: 9066745]
  4. Surveillance, Epidemiology, and End Results (SEER) Program. World Wide Web URL: www.seer.cancer.gov. SEER*Stat Database: SEER 17 Regs Nov 2005 sub (1973–2004). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistic Branch, 2006.
  5. Rindi G, Leiter AB, Kopin AS, et al. The “normal” endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci 2004;1014:1. [PMID: 15153415]
  6. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115. [PMID: 2986015]
  7. Crabtree JS, Scacheri PC, Ward JM, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A 2001;98:1118. [PMID: 11158604]
  8. Bertolino P, Tong WM, Galendo D, et al. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol 2003;17:1880. [PMID: 12819299]
  9. Dor ...